Zeesan Biotech
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Zeesan Biotech
More than 30 products have got CFDA approval and 17 products are CE marked for clinical use in Europe.
Zeesan Biotech
More than 30 products have got CFDA approval and 17 products are CE marked for clinical use in Europe.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Leukemia Fusion Genes (Q30) Screening Kit
Leukemia Fusion Genes (Q30) Screening Kit is a qualitative in vitro diagnostic test for screening of 30 fusion genes
resulted from chromosome translocations involved in chronic and acute leukemia. All the 30 fusion genes include more than
155 clinically relevant chromosomal breakpoints [1-9] . The kit detects RNA transcripts of fusion genes extracted from human
bone marrow or whole blood samples using a RT-qPCR procedure.
The fusion gene detected by the kit allows professionals to be more aware of the patient`s prognosis and provides
professionals important insights into the treatment planning.
Intended use: CE marked for IVD use in Europe
| Features | Specifications |
| Size | 20 tests/kit |
| Sample | bone marrow, whole blood and cell line |
| PCR instrument | Bio-Rad CFX96, Mx3005P/3000P, ABI7500, and SLAN 96s |
| Storage | -25°C ~ -18°C |
| Shelf Life | 12 months |
Please contact info@zsandx.com for further information.